Outlook Therapeutics, Inc. (OTLK:NASDAQ) shot up at $0.66, a gain of 39.9%. On Thu, Oct 19, 2023, OTLK:NASDAQ hit a New 2-Week High of $0.66. The stock appeared on our News Catalysts scanner on Wed, Oct 18, 2023 at 07:24 AM in the 'INVESTOR UPDATE' category. From Thu, Oct 05, 2023, the stock recorded 90.00% Up Days and 72.73% Green Days
The stock spiked on Thu, Oct 19, 2023 at $0.9 with a volume of 125M+.
About Outlook Therapeutics, Inc. (OTLK:NASDAQ)
Oncobiologics Inc is a clinical stage biopharmaceutical company. It is focused on identifying, developing, manufacturing and commercializing complex mAb therapeutics. The company has introduced BioSymphony Platform to produce high-quality innovative and biosimilar mAb candidates in an efficient and cost-effective manner.
Top 10 Gainers:
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 71.43%
- SeaStar Medical Inc Com (ICU:NASDAQ), 54.35%
- Mmtec, Inc. (MTC:NASDAQ), 51.47%
- Outlook Therapeutics, Inc. (OTLK:NASDAQ), 39.92%
- Spectral AI Inc. (MDAI:NASDAQ), 39.38%
- Atreca, Inc. (BCEL:NASDAQ), 35.87%
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 34.23%
- SAB Biotherapeutics Inc. (SABS:NASDAQ), 28.53%
- Mangoceuticals Inc. (MGRX:NASDAQ), 27.04%
- Hub Cyber Security Ltd. (HUBC:NASDAQ), 24.89%